Experimental hepatitis C drug shows promise for preventing recurrence in liver transplant patients
Friday, November 1, 2013 - 10:30
in Health & Medicine
New drug therapies offer promise to some hepatitis C sufferers whose transplanted livers are threated by a recurrence of the disease, including some patients who have had no treatment options.